Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine - European Medical Journal

Continue

Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine

Oncology

Prof. Solange Peters (Chair), Dr Anne-Marie Baird, Prof. Reinhard Büttner, and Dr Noemi Reguart, will discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges associated with this practice.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given